Roivant Sciences Ltd (ROIV) is a biotechnology company listed on US.
Latest reported ROIV revenue for 2026-03-31 was $8.3M. Net income was -$299.8M. Revenue was down 71.6% from 2025-03-31 to 2026-03-31. ROIV currently screens at market cap $7.47B.
Use this ROIV page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ROIV quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ROIV SEC filings page. Lician reads the product cache first so this HTML stays unique to Roivant Sciences Ltd even when a live quote feed is slow.
Latest cached year on this hub. Full ROIV income, balance, and cash tables.